MeSH term
Frequency | Condition_Probility | Humans | 57 | 0.0 |
Adult | 6 | 0.0 |
Aged | 7 | 0.0 |
Cytosol/metabolism | 2 | 0.0 |
Female | 6 | 0.0 |
Glucuronosyltransferase/*metabolism | 12 | 21.0 |
Liver/*enzymology | 3 | 0.0 |
Male | 15 | 0.0 |
Microsomes, Liver/*metabolism | 3 | 1.0 |
Middle Aged | 8 | 0.0 |
Recombinant Proteins/metabolism | 8 | 0.0 |
Animals | 14 | 0.0 |
Cell Line | 13 | 0.0 |
Chromatography, High Pressure Liquid | 6 | 0.0 |
Glucuronides/*metabolism | 6 | 37.0 |
In Vitro | 10 | 0.0 |
Isoenzymes/metabolism | 6 | 1.0 |
Microsomes, Liver/enzymology/metabolism | 3 | 4.0 |
Magnetic Resonance Spectroscopy | 2 | 0.0 |
Microsomes, Liver/enzymology/*metabolism | 3 | 3.0 |
Rats | 2 | 0.0 |
Research Support, Non-U.S. Gov't | 33 | 0.0 |
Comparative Study | 2 | 0.0 |
Glucuronic Acid/*metabolism | 3 | 100.0 |
Research Support, U.S. Gov't, P.H.S. | 13 | 0.0 |
Glucuronides/metabolism | 6 | 14.0 |
Microsomes, Liver/*enzymology/metabolism | 2 | 6.0 |
Spectrum Analysis, Mass | 7 | 1.0 |
Stereoisomerism | 3 | 0.0 |
Substrate Specificity | 9 | 0.0 |
Catalysis | 6 | 0.0 |
Kinetics | 13 | 0.0 |
Anti-Inflammatory Agents, Non-Steroidal/*metabolism | 2 | 22.0 |
Time Factors | 2 | 0.0 |
Genotype | 2 | 0.0 |
Polymorphism, Genetic | 2 | 0.0 |
Receptors, Estrogen/metabolism | 2 | 0.0 |
Risk Factors | 3 | 0.0 |
Testosterone/blood | 2 | 0.0 |
Biotransformation | 5 | 0.0 |
Gene Expression Regulation, Enzymologic/drug effects | 2 | 1.0 |
Glucuronosyltransferase/genetics/*metabolism | 7 | 19.0 |
Isoenzymes/genetics/metabolism | 2 | 1.0 |
Mice | 5 | 0.0 |
DNA, Complementary | 2 | 0.0 |
Microsomes, Liver/enzymology | 2 | 0.0 |
Enzyme Stability | 2 | 1.0 |
Glucuronosyltransferase/*chemistry/genetics/*metabolism | 2 | 66.0 |
RNA, Messenger/metabolism | 2 | 0.0 |
Steroids/*metabolism | 6 | 15.0 |
Tissue Distribution | 2 | 0.0 |
Aged, 80 and over | 2 | 0.0 |
Alleles | 3 | 0.0 |
Glucuronosyltransferase/*genetics | 8 | 7.0 |
Homozygote | 2 | 0.0 |
*Polymorphism, Genetic | 4 | 0.0 |
Cloning, Molecular | 5 | 0.0 |
Hamsters | 3 | 0.0 |
Isoenzymes/genetics | 2 | 0.0 |
Glucuronosyltransferase/antagonists & inhibitors/*metabolism | 2 | 25.0 |
Chromosome Mapping | 3 | 0.0 |
Gene Frequency | 2 | 0.0 |
In Situ Hybridization, Fluorescence | 2 | 0.0 |
*Multigene Family | 2 | 0.0 |
Promoter Regions (Genetics) | 3 | 0.0 |
Amino Acid Sequence | 6 | 0.0 |
Base Sequence | 4 | 0.0 |
Molecular Sequence Data | 9 | 0.0 |
Androgens/*metabolism | 3 | 5.0 |
Glucuronosyltransferase/*genetics/metabolism | 5 | 20.0 |
Liver/enzymology | 3 | 0.0 |
Prostate/enzymology | 3 | 5.0 |
Reverse Transcriptase Polymerase Chain Reaction | 3 | 0.0 |
Sequence Alignment | 3 | 0.0 |
Sequence Homology, Amino Acid | 2 | 0.0 |
Transfection | 5 | 0.0 |
*Gene Expression Regulation, Enzymologic | 2 | 0.0 |
Glucuronates/metabolism | 5 | 19.0 |
Macaca fascicularis | 2 | 0.0 |
Organ Specificity | 2 | 0.0 |
Gene Expression Regulation, Enzymologic | 2 | 0.0 |
Dogs | 2 | 0.0 |
Cell Division | 2 | 0.0 |
Dihydrotestosterone/metabolism | 2 | 3.0 |
Tumor Cells, Cultured | 4 | 0.0 |
Cell Division/drug effects | 2 | 0.0 |
Glucuronosyltransferase/*genetics/*metabolism | 3 | 42.0 |
Dose-Response Relationship, Drug | 2 | 0.0 |
DNA, Complementary/metabolism | 2 | 0.0 |
Hydrolysis | 2 | 0.0 |
Cells, Cultured | 2 | 0.0 |
Coumarins/metabolism | 2 | 8.0 |
Flavonoids/metabolism | 2 | 22.0 |
Phenols/metabolism | 2 | 20.0 |
Xenobiotics/*metabolism | 2 | 3.0 |
Adolescent | 2 | 0.0 |
Child | 2 | 0.0 |
Chromatography, Liquid | 2 | 1.0 |
Microsomes, Liver/metabolism | 5 | 2.0 |
Microsomes, Liver/*enzymology | 2 | 1.0 |
